Anna Schandl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna Schandl has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
Pernilla Lagergren
Department of Molecular Medicine and Surgery, Karolinska Institutet, Sweden; Department of Surgery and Cancer, Imperial College London, United Kingdom
14 shared publicationsAsif Johar
Surgical Care Science, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
11 shared publications- Pernilla Lagergren
Surgical Care Science, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Surgery and Cancer, Imperial College London, United Kingdom
8 shared publications Kalle Mälberg
Surgical Care Science, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
7 shared publications- Matteo Bottai
Division of Biostatistics Institute of Environmental Medicine Karolinska Institutet
5 shared publications - Elisabeth Hellgren
Department of Anesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital Solna, Stockholm, 17176, Sweden
4 shared publications
Latest Publications
- 24 September 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (10)
Response to Letter to the Editor: “Free of Delirium” Must Not Mean “Never Assessable” in CoreMS ‐ ICU
- 24 September 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (10)
Response to Letter to the Editor: “Free of Delirium” Must Not Mean “Never Assessable” in CoreMS ‐ ICU
- Open Access
- 16 June 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (6) , e70278
Developing a Core Outcome Measurement Set for Adult ICU Patients, the CoreMS ‐ ICU —A Protocol
Background: Core outcome measurement sets (COMS) enhance the consistency and comparability of outcome reporting in clinical research. However, their effectiveness depends on the selection of valid, reliable, and feasible measurement instruments. Core outcome sets (COS) and COMS have been developed for specific intensive care unit (ICU) patient subgroups. The aim of this study is to establish a standardised approach to outcome measurement and operationalisation for adults acutely admitted to the ICU who are participating in clinical trials and other clinical research. Methods: This protocol describes the development of a COMS for adults acutely admitted to the ICU, the CoreMS‐ICU, consisting of six core outcomes: survival, free of life support, free of delirium, out of hospital, health‐related quality of life, and cognitive function. We will follow the Consensus‐based Standards for the Selection of Health Measurement Instruments guideline and report according to the Core Outcome Set—STAndardised Protocol Items guideline. The development of the CoreMS‐ICU will follow five predefined steps: (1) conceptual considerations for the six core outcomes; (2) systematic searches for outcome measurement instruments, including consideration of existing COMS; (3) quality assessment of relevant outcome measurement instruments; (4) consensus‐based selection of outcome measurement instruments; and (5) recommendations and guidance on how to operationalise and report the measurement of the six core outcomes. We will involve research panels consisting of key stakeholders: patients, family members, healthcare professionals, and researchers in steps 1 and 4. Conclusions: We aim to develop a COMS for adults acutely admitted to ICU patients to facilitate the consistent use of outcomes in trials and enhance the translation of research findings into clinical practice.
- 16 June 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (6) , e70278
Open AccessDeveloping a Core Outcome Measurement Set for Adult ICU Patients, the CoreMS ‐ ICU —A Protocol
Background: Core outcome measurement sets (COMS) enhance the consistency and comparability of outcome reporting in clinical research. However, their effectiveness depends on the selection of valid, reliable, and feasible measurement instruments. Core outcome sets (COS) and COMS have been developed for specific intensive care unit (ICU) patient subgroups. The aim of this study is to establish a standardised approach to outcome measurement and operationalisation for adults acutely admitted to the ICU who are participating in clinical trials and other clinical research. Methods: This protocol describes the development of a COMS for adults acutely admitted to the ICU, the CoreMS‐ICU, consisting of six core outcomes: survival, free of life support, free of delirium, out of hospital, health‐related quality of life, and cognitive function. We will follow the Consensus‐based Standards for the Selection of Health Measurement Instruments guideline and report according to the Core Outcome Set—STAndardised Protocol Items guideline. The development of the CoreMS‐ICU will follow five predefined steps: (1) conceptual considerations for the six core outcomes; (2) systematic searches for outcome measurement instruments, including consideration of existing COMS; (3) quality assessment of relevant outcome measurement instruments; (4) consensus‐based selection of outcome measurement instruments; and (5) recommendations and guidance on how to operationalise and report the measurement of the six core outcomes. We will involve research panels consisting of key stakeholders: patients, family members, healthcare professionals, and researchers in steps 1 and 4. Conclusions: We aim to develop a COMS for adults acutely admitted to ICU patients to facilitate the consistent use of outcomes in trials and enhance the translation of research findings into clinical practice.
- Open Access
- 22 May 2026
- Published by Elsevier in European Journal of Oncology Nursing
- Vol. 82, 103219
Patients’ experiences of gastro-oesophageal reflux after oesophagectomy for cancer – a qualitative study
- 22 May 2026
- Published by Elsevier in European Journal of Oncology Nursing
- Vol. 82, 103219
Open AccessPatients’ experiences of gastro-oesophageal reflux after oesophagectomy for cancer – a qualitative study
- Open Access
Early mobilisation after abdominal surgery: a concept analysis
Objective To clarify and define the clinical practice concept of early mobilisation after abdominal surgery. Design A concept analysis guided by Walker and Avant’s method. Data sources MEDLINE (Ovid), AMED-(Ovid), Embase (Elsevier) and CINAHL (EBSCO) were searched through 5 December 2024. Eligibility criteria Relevant studies that included combinations of the terms ‘early mobilisation’, ‘early ambulation’, ‘early acceleration’, ‘abdominal surgery’ and ‘surgical procedures’ were selected. We restricted the search to English full-text publications involving adult patients, limited to the year 2000 and onward. Inclusion criteria were original research articles describing the timing and/or type of mobilisation. Data extraction and synthesis The study derives its defining attributes, antecedents and consequences through data analysis. To enhance understanding of the model, we constructed related and contrary cases of the concept and outlined relevant empirical referents. Results In total, 140 studies were included in the analysis. Early mobilisation is characterised by the key defining attributes of initiating active physical movement, including standing, sitting in a chair or walking, within the first 24 hours of surgery. Antecedents include haemodynamic and respiratory stability, adequate pain management, and the patient’s cognitive and physical readiness. Contextual antecedents include competent and adequately staffed healthcare teams. Consequences include improved physiological recovery and enhanced postoperative outcomes. Conclusions This analysis provides a clarified, practice-focused definition of early mobilisation after abdominal surgery. By delineating its key attributes and contextual prerequisites, the study offers a conceptual foundation that can support clinical guidelines, promote consistent implementation and inform future research aimed at optimising postoperative recovery.
Open AccessEarly mobilisation after abdominal surgery: a concept analysis
Objective To clarify and define the clinical practice concept of early mobilisation after abdominal surgery. Design A concept analysis guided by Walker and Avant’s method. Data sources MEDLINE (Ovid), AMED-(Ovid), Embase (Elsevier) and CINAHL (EBSCO) were searched through 5 December 2024. Eligibility criteria Relevant studies that included combinations of the terms ‘early mobilisation’, ‘early ambulation’, ‘early acceleration’, ‘abdominal surgery’ and ‘surgical procedures’ were selected. We restricted the search to English full-text publications involving adult patients, limited to the year 2000 and onward. Inclusion criteria were original research articles describing the timing and/or type of mobilisation. Data extraction and synthesis The study derives its defining attributes, antecedents and consequences through data analysis. To enhance understanding of the model, we constructed related and contrary cases of the concept and outlined relevant empirical referents. Results In total, 140 studies were included in the analysis. Early mobilisation is characterised by the key defining attributes of initiating active physical movement, including standing, sitting in a chair or walking, within the first 24 hours of surgery. Antecedents include haemodynamic and respiratory stability, adequate pain management, and the patient’s cognitive and physical readiness. Contextual antecedents include competent and adequately staffed healthcare teams. Consequences include improved physiological recovery and enhanced postoperative outcomes. Conclusions This analysis provides a clarified, practice-focused definition of early mobilisation after abdominal surgery. By delineating its key attributes and contextual prerequisites, the study offers a conceptual foundation that can support clinical guidelines, promote consistent implementation and inform future research aimed at optimising postoperative recovery.
- Open Access
- 16 March 2026
- Published by Elsevier in International Journal of Nursing Studies Advances
- Vol. 10, 100522
Professional altruism in nursing care: A concept clarification study
- 16 March 2026
- Published by Elsevier in International Journal of Nursing Studies Advances
- Vol. 10, 100522
Open AccessProfessional altruism in nursing care: A concept clarification study
- Open Access
- 5 March 2026
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 65, 186-192
Prediction of dumping after oesophageal cancer surgery
Introduction: Dumping syndrome is a common consequence following oesophagectomy and may lead to reduced food intake, resulting in subsequent weight loss, and negatively impact health-related quality of life. This study aimed to develop a predictive model to facilitate preventive treatment planning by identifying individuals at an increased risk of developing dumping syndrome. Materials and methods: Data were obtained from a nationwide, population-based cohort of patients who underwent oesophagectomy for cancer between 2013 and 2020. Patient and clinical characteristics were retrieved from national health registries and medical records. Dumping symptoms were self-reported 1 year after surgery. Multivariable regression models provided odds ratios (OR) with 95% confidence intervals (CI). Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). Results: Among the 384 individuals, 41 (11%) developed significant symptoms of dumping. The following variables that increased the probability of developing dumping were included in the final prediction model: younger age, female sex, higher preoperative body mass index, no neoadjuvant therapy, Charlson Comorbidity Index score > 0, open oesophagectomy, cervical anastomosis, and less severe postoperative complications (lower Clavien Dindo grade). For the prediction of early dumping symptoms, the AUC for the total cohort was 0.74 (95% CI: 0.64–0.83) and after cross-validation, 0.62 (95% CI: 0.53–0.72). For early and late symptoms, the AUC was 0.75 (95% CI: 0.67–0.83), and for the cross-validated model, 0.65 (95% CI: 0.56–0.74). Interpretation: This study offers insights into factors associated with dumping syndrome after oesophagectomy. The prediction model showed modest ability to distinguish between high and low-risk patients, and should therefore be interpreted as supportive rather than definitive. Its potential value lies in complementing clinical judgement, informing structured follow-up and guiding future research.
- 5 March 2026
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 65, 186-192
Open AccessPrediction of dumping after oesophageal cancer surgery
Introduction: Dumping syndrome is a common consequence following oesophagectomy and may lead to reduced food intake, resulting in subsequent weight loss, and negatively impact health-related quality of life. This study aimed to develop a predictive model to facilitate preventive treatment planning by identifying individuals at an increased risk of developing dumping syndrome. Materials and methods: Data were obtained from a nationwide, population-based cohort of patients who underwent oesophagectomy for cancer between 2013 and 2020. Patient and clinical characteristics were retrieved from national health registries and medical records. Dumping symptoms were self-reported 1 year after surgery. Multivariable regression models provided odds ratios (OR) with 95% confidence intervals (CI). Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). Results: Among the 384 individuals, 41 (11%) developed significant symptoms of dumping. The following variables that increased the probability of developing dumping were included in the final prediction model: younger age, female sex, higher preoperative body mass index, no neoadjuvant therapy, Charlson Comorbidity Index score > 0, open oesophagectomy, cervical anastomosis, and less severe postoperative complications (lower Clavien Dindo grade). For the prediction of early dumping symptoms, the AUC for the total cohort was 0.74 (95% CI: 0.64–0.83) and after cross-validation, 0.62 (95% CI: 0.53–0.72). For early and late symptoms, the AUC was 0.75 (95% CI: 0.67–0.83), and for the cross-validated model, 0.65 (95% CI: 0.56–0.74). Interpretation: This study offers insights into factors associated with dumping syndrome after oesophagectomy. The prediction model showed modest ability to distinguish between high and low-risk patients, and should therefore be interpreted as supportive rather than definitive. Its potential value lies in complementing clinical judgement, informing structured follow-up and guiding future research.
- Open Access
- 11 February 2026
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 12 (1) , e82448
The Longevity of Mobile Apps for Cancer Recovery: Scoping Review
Background: The number of cancer survivors is steadily increasing worldwide, leading to an increased demand for long-term follow-up and supportive care. Many survivors face ongoing physical and psychosocial issues that highlight the need for innovative management approaches. Mobile health apps offer potential benefits by facilitating patient-led follow-up, self-management, and more efficient use of health care resources. Although the market for cancer-related mobile apps has grown rapidly, their sustainability and scientific basis remain unclear. In the European Union, the Medical Device Regulation (MDR), in effect since May 2021, introduced stricter criteria for classifying medical devices, including certain software apps. While aiming to improve patient safety, the MDR could pose challenges for small companies and academic developers, potentially limiting the availability of such apps. No scoping review has delineated changes in active apps before and after implementation of the legislation regulating medical devices. Objective: This scoping review aimed to evaluate the current availability and longevity of English-language mobile apps supporting cancer recovery, with a specific focus on changes before and after the implementation of the European Union MDR, and to assess the extent to which these apps are supported by clinical evidence. Methods: Searches were conducted in mobile app stores (Apple’s App Store and Google Play) and literature databases (MEDLINE, Embase, Cochrane Library, and Web of Science), using predefined terms. Mobile apps targeting cancer recovery and published articles on their effectiveness were included. Two reviewers independently extracted data. A descriptive analysis was conducted to report trends in mobile device app availability and updates over time. Results: A total of 151 mobile apps were identified in 2018. However, by 2024, only 45 of 151 (30%) were still available. Among these, 25 of 151 (17%) were updated within the past 2 years. During the search in December 2024, 1 new mobile app supported by scientific evidence was discovered. This mobile app was developed to assist cancer survivors in managing insomnia through cognitive behavioral therapy. Rapid turnover and a potential lack of sustainability in the mobile health app market for cancer survivors were evident, with most mobile apps identified in 2018 no longer available by 2024. Conclusions: This review revealed a limited number of publicly available mobile apps that support cancer recovery. The longevity of existing mobile apps is limited, potentially because of regulatory and financial barriers. Prioritizing rigorous effectiveness trials, addressing implementation barriers, and developing sustainable business models are essential to ensure the long-term availability and success of mobile health apps in cancer survivorship care.
- 11 February 2026
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 12 (1) , e82448
Open AccessThe Longevity of Mobile Apps for Cancer Recovery: Scoping Review
Background: The number of cancer survivors is steadily increasing worldwide, leading to an increased demand for long-term follow-up and supportive care. Many survivors face ongoing physical and psychosocial issues that highlight the need for innovative management approaches. Mobile health apps offer potential benefits by facilitating patient-led follow-up, self-management, and more efficient use of health care resources. Although the market for cancer-related mobile apps has grown rapidly, their sustainability and scientific basis remain unclear. In the European Union, the Medical Device Regulation (MDR), in effect since May 2021, introduced stricter criteria for classifying medical devices, including certain software apps. While aiming to improve patient safety, the MDR could pose challenges for small companies and academic developers, potentially limiting the availability of such apps. No scoping review has delineated changes in active apps before and after implementation of the legislation regulating medical devices. Objective: This scoping review aimed to evaluate the current availability and longevity of English-language mobile apps supporting cancer recovery, with a specific focus on changes before and after the implementation of the European Union MDR, and to assess the extent to which these apps are supported by clinical evidence. Methods: Searches were conducted in mobile app stores (Apple’s App Store and Google Play) and literature databases (MEDLINE, Embase, Cochrane Library, and Web of Science), using predefined terms. Mobile apps targeting cancer recovery and published articles on their effectiveness were included. Two reviewers independently extracted data. A descriptive analysis was conducted to report trends in mobile device app availability and updates over time. Results: A total of 151 mobile apps were identified in 2018. However, by 2024, only 45 of 151 (30%) were still available. Among these, 25 of 151 (17%) were updated within the past 2 years. During the search in December 2024, 1 new mobile app supported by scientific evidence was discovered. This mobile app was developed to assist cancer survivors in managing insomnia through cognitive behavioral therapy. Rapid turnover and a potential lack of sustainability in the mobile health app market for cancer survivors were evident, with most mobile apps identified in 2018 no longer available by 2024. Conclusions: This review revealed a limited number of publicly available mobile apps that support cancer recovery. The longevity of existing mobile apps is limited, potentially because of regulatory and financial barriers. Prioritizing rigorous effectiveness trials, addressing implementation barriers, and developing sustainable business models are essential to ensure the long-term availability and success of mobile health apps in cancer survivorship care.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Nursing Management
- Vol. 2026 (1)
First Line Managers’ Experiences of Shaping Organisational and Relational Preconditions for Patient Safety in Swedish Intensive Care Units During the COVID‐19 Pandemic: A Qualitative Study
Objectives: The COVID‐19 pandemic placed extraordinary demands on intensive care units (ICUs), posing significant challenges to patient safety and underscoring the critical role of healthcare managers. Although leadership has been widely studied during the pandemic, little is known about how first‐line ICU managers experienced their work supporting staff and shaping organisational and relational preconditions for patient safety. This qualitative study aimed to address this gap by exploring first‐line ICU managers’ descriptions of their work during the pandemic. Methods: Individual interviews were conducted with 15 first‐line managers (nurses and physicians) who had operational responsibility for ICU staff, including nurses, physicians and assistant nurses, during the first wave of the COVID‐19 pandemic (1 March–30 September 2020). Participants were recruited from five ICUs across three Swedish hospitals. Data were analysed using thematic analysis. Results: The first‐line managers’ experiences were described in three themes: Balancing resources, workload and the well‐being of ICU staff; fostering a responsive and adaptive work environment; and building trust and collaboration. According to the first‐line managers, they experienced conflicts between maintaining efficiency and ensuring preconditions for patient safety, often struggling to balance care with limited resources. They explained how flexibility, continuous learning and mutual trust contributed to an adaptable healthcare environment that enabled the identification of safety risks. Conclusions: This study highlights the unique role of first‐line managers in shaping organisational preconditions for patient safety in ICUs during the COVID‐19 pandemic. Their leadership was enacted in real time, embedded in clinical care, shaped by ethical complexity, resource constraints and the need to support staff well‐being. The findings reveal how adaptive leadership, characterised by flexibility, continuous learning and trust, enabled managers to respond effectively to rapidly changing conditions and maintain patient safety under pressure. Implications for Nursing Management: The results underscore the importance of equipping first‐line managers with leadership competencies that promote adaptability, trust‐building, and continuous learning, especially in high‐pressure environments such as ICUs. By demonstrating how managers balanced staff well‐being, resource constraints, and preconditions for patient safety, this study offers practical strategies to strengthen resilience in healthcare teams. These insights can inform leadership development programmes, organisational policies and system‐level reforms aimed at enhancing patient safety and preparedness for future healthcare crises.
- 1 January 2026
- Published by Wiley in Journal of Nursing Management
- Vol. 2026 (1)
Open AccessFirst Line Managers’ Experiences of Shaping Organisational and Relational Preconditions for Patient Safety in Swedish Intensive Care Units During the COVID‐19 Pandemic: A Qualitative Study
Objectives: The COVID‐19 pandemic placed extraordinary demands on intensive care units (ICUs), posing significant challenges to patient safety and underscoring the critical role of healthcare managers. Although leadership has been widely studied during the pandemic, little is known about how first‐line ICU managers experienced their work supporting staff and shaping organisational and relational preconditions for patient safety. This qualitative study aimed to address this gap by exploring first‐line ICU managers’ descriptions of their work during the pandemic. Methods: Individual interviews were conducted with 15 first‐line managers (nurses and physicians) who had operational responsibility for ICU staff, including nurses, physicians and assistant nurses, during the first wave of the COVID‐19 pandemic (1 March–30 September 2020). Participants were recruited from five ICUs across three Swedish hospitals. Data were analysed using thematic analysis. Results: The first‐line managers’ experiences were described in three themes: Balancing resources, workload and the well‐being of ICU staff; fostering a responsive and adaptive work environment; and building trust and collaboration. According to the first‐line managers, they experienced conflicts between maintaining efficiency and ensuring preconditions for patient safety, often struggling to balance care with limited resources. They explained how flexibility, continuous learning and mutual trust contributed to an adaptable healthcare environment that enabled the identification of safety risks. Conclusions: This study highlights the unique role of first‐line managers in shaping organisational preconditions for patient safety in ICUs during the COVID‐19 pandemic. Their leadership was enacted in real time, embedded in clinical care, shaped by ethical complexity, resource constraints and the need to support staff well‐being. The findings reveal how adaptive leadership, characterised by flexibility, continuous learning and trust, enabled managers to respond effectively to rapidly changing conditions and maintain patient safety under pressure. Implications for Nursing Management: The results underscore the importance of equipping first‐line managers with leadership competencies that promote adaptability, trust‐building, and continuous learning, especially in high‐pressure environments such as ICUs. By demonstrating how managers balanced staff well‐being, resource constraints, and preconditions for patient safety, this study offers practical strategies to strengthen resilience in healthcare teams. These insights can inform leadership development programmes, organisational policies and system‐level reforms aimed at enhancing patient safety and preparedness for future healthcare crises.
- Open Access
- 27 November 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (2) , 111302
Sex and age differences in longitudinal health-related quality of life: A population-based cohort study of oesophageal cancer survivors in Sweden
- 27 November 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (2) , 111302
Open AccessSex and age differences in longitudinal health-related quality of life: A population-based cohort study of oesophageal cancer survivors in Sweden
- Open Access
- 27 March 2025
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 69 (5) , e70031
Identifying dysphagia in the intensive care unit: Validation of the Swedish version of the Gugging swallowing screen—Intensive care unit
Background: Dysphagia is independently associated with adverse outcomes in intensive care units (ICU). Early identification through dysphagia screening does not occur routinely, negatively impacting optimal patient management. This study aimed to validate the Swedish version of the Gugging Swallowing Screen—Intensive Care Unit (GUSS‐IVA).Methods: This is a prospective multicentre study of 56 adult ICU patients with endotracheal intubation exceeding 48 h at three hospitals in Sweden. The GUSS‐ICU was translated into Swedish (GUSS‐IVA) and used to screen all prolonged intubated patients (>48 h) once extubated. The GUSS‐IVA screen was conducted by ICU nursing staff and then compared with a gold standard Flexible Endoscopic Evaluation of Swallowing (FEES) within 2 h of the GUSS‐IVA screen. Fifty‐one of 56 patients underwent FEES (where assessors were blinded to the GUSS‐IVA screen results). Sensitivity and specificity were calculated, as was the area under the receiver operating characteristic curves (AUC) with 95% confidence intervals (CI). For inter‐rater reliability, within 2 h of the initial screen, 29/56 patients were GUSS‐IVA screened a second time by a nursing staff blinded to the first GUSS‐IVA results.Results: Among the 56 patients, 38 (67.9%) were identified as dysphagic using the GUSS‐IVA screen. With FEES, 42 of 51 patients (82.4%) were diagnosed with dysphagia; of these, 16 (31.4%) were classified as aspirating. Compared to FEES, GUSS‐IVA showed high sensitivity and specificity values (81% and 89%, respectively) with an AUC of 0.85 (95% CI: 0.71–0.95) and a positive predictive value of 97%. High convergent validity was obtained for GUSS‐IVA compared with the Dysphagia Outcome Severity Scale (ɸ = 0.57, p < .001) and the Functional Oral Intake Scale (ɸ = 0.52, p < .001) and moderate validity with the Penetration‐Aspiration Scale (ɸ = 0.30, p = .033). The inter‐rater reliability showed moderate agreement (Cohen's kappa κ = 0.501, p = .006).Conclusions: This study indicates that the Swedish GUSS‐IVA is a valid and reliable screen to identify dysphagic ICU patients. Given the negative impact of dysphagia on short and long‐term patient outcomes, the Swedish GUSS‐IVA is recommended as an essential first step by nursing staff for early identification of dysphagia for further diagnostics and subsequent patient management.
- 27 March 2025
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 69 (5) , e70031
Open AccessIdentifying dysphagia in the intensive care unit: Validation of the Swedish version of the Gugging swallowing screen—Intensive care unit
Background: Dysphagia is independently associated with adverse outcomes in intensive care units (ICU). Early identification through dysphagia screening does not occur routinely, negatively impacting optimal patient management. This study aimed to validate the Swedish version of the Gugging Swallowing Screen—Intensive Care Unit (GUSS‐IVA).Methods: This is a prospective multicentre study of 56 adult ICU patients with endotracheal intubation exceeding 48 h at three hospitals in Sweden. The GUSS‐ICU was translated into Swedish (GUSS‐IVA) and used to screen all prolonged intubated patients (>48 h) once extubated. The GUSS‐IVA screen was conducted by ICU nursing staff and then compared with a gold standard Flexible Endoscopic Evaluation of Swallowing (FEES) within 2 h of the GUSS‐IVA screen. Fifty‐one of 56 patients underwent FEES (where assessors were blinded to the GUSS‐IVA screen results). Sensitivity and specificity were calculated, as was the area under the receiver operating characteristic curves (AUC) with 95% confidence intervals (CI). For inter‐rater reliability, within 2 h of the initial screen, 29/56 patients were GUSS‐IVA screened a second time by a nursing staff blinded to the first GUSS‐IVA results.Results: Among the 56 patients, 38 (67.9%) were identified as dysphagic using the GUSS‐IVA screen. With FEES, 42 of 51 patients (82.4%) were diagnosed with dysphagia; of these, 16 (31.4%) were classified as aspirating. Compared to FEES, GUSS‐IVA showed high sensitivity and specificity values (81% and 89%, respectively) with an AUC of 0.85 (95% CI: 0.71–0.95) and a positive predictive value of 97%. High convergent validity was obtained for GUSS‐IVA compared with the Dysphagia Outcome Severity Scale (ɸ = 0.57, p < .001) and the Functional Oral Intake Scale (ɸ = 0.52, p < .001) and moderate validity with the Penetration‐Aspiration Scale (ɸ = 0.30, p = .033). The inter‐rater reliability showed moderate agreement (Cohen's kappa κ = 0.501, p = .006).Conclusions: This study indicates that the Swedish GUSS‐IVA is a valid and reliable screen to identify dysphagic ICU patients. Given the negative impact of dysphagia on short and long‐term patient outcomes, the Swedish GUSS‐IVA is recommended as an essential first step by nursing staff for early identification of dysphagia for further diagnostics and subsequent patient management.